Mark Lackner - Net Worth and Insider Trading
Mark Lackner Net Worth
The estimated net worth of Mark Lackner is at least $2 Million dollars as of 2024-05-26. Mark Lackner is the Chief Scientific Officer of Zentalis Pharmaceuticals Inc and owns about 195,728 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $2 Million. Mark Lackner is also the SVP, Head of Biology of IDEAYA Biosciences Inc and owns about 0 shares of IDEAYA Biosciences Inc (IDYA) stock worth over $0. Details can be seen in Mark Lackner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Lackner has not made any transactions after 2024-02-02 and currently still holds the listed stock(s).
Transaction Summary of Mark Lackner
Mark Lackner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Lackner owns 1 companies in total, including IDEAYA Biosciences Inc (IDYA) .
Click here to see the complete history of Mark Lackner’s form 4 insider trades.
Insider Ownership Summary of Mark Lackner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IDYA | IDEAYA Biosciences Inc | 2021-02-10 | SVP & Head of Biology |
Mark Lackner Latest Holdings Summary
Mark Lackner currently owns a total of 2 stocks. Among these stocks, Mark Lackner owns 195,728 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of February 2, 2024, with a value of $2 Million and a weighting of 100%. Mark Lackner also owns 0 shares of IDEAYA Biosciences Inc (IDYA) as of February 10, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Mark Lackner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-02-02 | 195,728 | 11.27 | 2,205,855 |
| IDYA | IDEAYA Biosciences Inc | 2021-02-10 | 0 | 37.71 | 0 |
Holding Weightings of Mark Lackner
Mark Lackner Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Lackner has made a total of 1 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 1,585 shares on February 2, 2024, which brought Mark Lackner around $18,291.
According to the SEC Form 4 filings, Mark Lackner has made a total of 4 transactions in IDEAYA Biosciences Inc (IDYA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in IDEAYA Biosciences Inc is the sale of 2,000 shares on February 10, 2021, which brought Mark Lackner around $42,060.
Insider Trading History of Mark Lackner
- 1
Mark Lackner Trading Performance
Mark Lackner Ownership Network
Mark Lackner Owned Company Details
What does IDEAYA Biosciences Inc do?
Who are the key executives at IDEAYA Biosciences Inc?
Mark Lackner is the SVP & Head of Biology of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include director & President and CEO Yujiro S Hata , See Remarks Briseno Andres Ruiz , and VP & General Counsel Jason Throne .
IDEAYA Biosciences Inc (IDYA) Insider Trades Summary
Over the past 18 months, Mark Lackner made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 38,970 shares made by Jason Throne , a net sale of 425,000 shares made by Yujiro S Hata , and a net sale of 10,000 shares made by Briseno Andres Ruiz .
In summary, during the past 3 months, insiders sold 175,000 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 175,000 shares. During the past 18 months, 486,470 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,470 shares.
IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEAYA Biosciences Inc Insider Transactions
Mark Lackner Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Lackner. You might contact Mark Lackner via mailing address: C/o Ideaya Biosciences, Inc., 7000 Shoreline Court, Suite 350, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
